Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Volume 35, Issue / 2025
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article Greetings of the chairperson of CPCR2025 combination meet
今村武史1, 山本一博2
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 1-2, 2025.
Japanese Article SP1. The multifaceted effect and cardioprotection effect of the SGLT2 inhibitor: The new development that we saw from a metabolism signal
金井好克
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 26-26, 2025.
Japanese Article SP2. Autonomic nerve control and high blood pressure of the salt sensitivity
檜山武史
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 28-28, 2025.
Japanese Article S1-1. Role of the summer sleep-like response in the organ protection that SGLT2 inhibitor results in
西山成, 北田研人
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 31-31, 2025.
Japanese Article S1-2. Mainly on diabetes treatment - GLP-1 preparation aiming at cardiovascular events, heart failure onset inhibition -
桑原宏一郎
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 32-32, 2025.
Japanese Article S1-3. Topics about the condition of a patient and the treatment of type 2 diabetes
金藤秀明
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 33-33, 2025.
Japanese Article S2-1. Role of iron as the life metallic element
池田康将
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 35-35, 2025.
Japanese Article S2-2. Cancer microenvironment remodeling through the hypoxia signal
冨田修平
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 36-36, 2025.
Japanese Article S2-3. Oxygen environment and cardiovascular remodeling
武田憲彦
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 37-37, 2025.
Japanese Article SY1. The condition of a patient elucidation and therapy development of the rare cardiomyopathy to become quiescent for severe heart failure
肥後修一朗
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 39-39, 2025.
Japanese Article SY2. As much as support the ability to regenerate of the neonates heart; the elucidation of the fruit body and the implementation to mature form heart
木村航
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 40-40, 2025.
Japanese Article SY3. Molecular mechanism elucidation of the cardiogenesis using the cytodifferentiation conversion method
橋本寿之, 中村貴裕, 小室仁, 小室薫子, 家田真樹
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 41-41, 2025.
Japanese Article SY4. Candidate treatment compound search of the LMNA mutation cardiomyopathy using iPS cells
伊藤正道
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 42-42, 2025.
Japanese Article YIA1. The cancer molecules target medicine Osimertinib induces a myocardium heartbeat disorder through lysosome dysfunction and mTORC1 signal inhibition
森原啓文1, 満屋奨2, 友田紀一郎3, 藤阪保仁2, 高井真司1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 44-44, 2025.
Japanese Article YIA2. The effect that the CaMKII/RyR2 activation in the obese mice model gives in atrial fibrillation inducibility
澤野達哉1, 三明淳一朗1, 友森匠也2, 高見亜衣子2, 岡村昌宏2, 加藤克2, 市原克則1, 長田佳子1, 山本一博3, 今村武史1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 45-45, 2025.
Japanese Article YIA3. The condition of a patient control of the high blood pressure due to the target gene of miRNA which develops in the vesicle derived from spontaneously hypertensive rat plasma out of the cells, and is enhanced
藤岡友星, 大谷紘資, 宮下結衣, 武内春樹, 岡田宗善, 山脇英之
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 46-46, 2025.
Japanese Article YIA4. RAMP3 controls a cancer cell and crosstalk of the tumor microenvironment and promotes the malignant transformation of tumor
甲斐健佑, 田中愛, Zhang Yan, 桜井敬之, 神吉昭子, 新藤優佳, Guo Qianqian, Li Peixuan, Li Jaike, 星山健, Duan Jun, 林真倫那, 新藤隆行
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 47-47, 2025.
Japanese Article YIA5. By inhibiting IFN-γ/STAT1 signal, YAP of cardiac muscle cells induces the myocardium restoration remodeling after the myocarditis end
亀谷祐介, 田中翔大, 岡田欣晃, 尾花理徳, 藤尾慈
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 48-48, 2025.
Japanese Article YIA6. Protection of the Orengedokuto for the doxorubicin cardiotoxicity and participation of the cGAS/STING/IRF3 course
山本みずほ1, 船本雅文1, 今西正樹2, 土屋浩一郎2, 池田康将1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 49-49, 2025.
Japanese Article YIA7. Development of the fat cell differentiation antagonist which assumes primary cilia a target
中野仁嗣1,2, 白水崇1, 稲垣昌樹3, 西村有平1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 50-50, 2025.
Japanese Article O1. The soluble guanylate cyclase stimulant riociguat suppresses the thickening of isolated rat mitral valves by inhibiting TGF-β-mediated transformation of valve interstitial cells.
佐藤伶美, 柴原彩, 酒居幸生, 亀島聡
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 52-52, 2025.
Japanese Article O2. The development of 1 cells RNA sequence analysis tool and the applied case
冨松聖史, 田中翔大, 岡田欣晃, 尾花理徳, 藤尾慈
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 53-53, 2025.
Japanese Article O3. Difference of the water balance of blood and the each tissue in the high fat diet load mouse
北田研人, Kundo Netish Kumar, 藤澤良秀, 西山成
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 54-54, 2025.
Japanese Article O4. Change of type IV collagen α 2 chain decomposition piece canstatin expression in diabetic nephropathy
岡田宗善, 横山敬亮, 藤岡友星, 大谷紘資, 山脇英之
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 55-55, 2025.
Japanese Article O5. Compensatory mechanism through the Neuregulin1-ErbB2/ErbB4 axis in the diabetic cardiomyopathy
赤羽悟美, 三上義礼, 大島大輔, 鄭有人, 冨田太一郎
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 56-56, 2025.
Japanese Article O6. Role of NR4A1 in the vascular smooth muscle cell death by the hypertensive extension stimulation and the automatic fuzzy association factor
趙晶1, 中平毅一1, 京谷陽司1, 中村修平2, 吉栖正典1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 57-57, 2025.
Japanese Article O7. Analysis of the gene expression change of vascular endothelial cells depending on extracellular environmental hardness
岡本貴行, 臼田春樹, 和田孝一郎
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 58-58, 2025.
Japanese Article O8. Development of the new therapy for the familial adenomatous polyposis that targeted ATP6ap2
西山成
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 59-59, 2025.
Japanese Article P1. Na+, the K+-ATPase (α 2) inhibition improve the sustained allodynia of the neuropathic pain mouse
根本隆行1, 落合晋2, 喜多知1, 篠田康晴1, 小松知広1, 柴田志保2, 秋吉浩三郎2, 池田啓子4, 川上潔4, 喜多紗斗美3, 岩本隆宏1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 61-61, 2025.
Japanese Article P2. The AM-RAMP3 system maintains metabolism after myocardial infarction and a mitochondrial function and acts on cardioprotection
Li Peixuan1, 神吉昭子1,2, 桜井敬之1,2, 田中愛1,2, 新藤優佳1, Zhang Yan1, Guo Qianqian1, 星山健1, Li Jiake1, Duan Jun1, 林真倫那1, 赤平あすか1, 新藤隆行1,2
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 62-62, 2025.
Japanese Article P3. Expression of Gicerin/CD146 control structure in the cardiac muscle cells through the TGF-β-Smad/ non-Smad signal
小原真美, Hasan Alif Ul, 佐藤幸子, 近藤ゆき子, 平英一
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 63-63, 2025.
Japanese Article P4. Mitochondrial control and heart aging conquest by the lncRNA Caren-HINT1 course
佐藤迪夫1,2, 門松毅1, 野出孝一2, 尾池雄一1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 64-64, 2025.
Japanese Article P5. Heart rate adjustment through the epigenetics control by the multifunctional protease
大野美紀子1,3, 松浦博2, 西清人1, 牧山武3, 豊田太4, 池田真也1, 糀谷泰彦3, Ganbaatar Narangerel1, ENKHJIN GANSUKH1, 大林徹也5, 西英一郎1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 65-65, 2025.
Japanese Article P6. The null D rye gin controls expression of GLUT2 in the beta cells of pancreas
西清人1, Ganbaatar Narangerel1, 大野美紀子1, 池田真也1, 岩崎広高1,2, 西英一郎1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 66-66, 2025.
Japanese Article P7. The reinforcement of the calcium signal by the fat droplet composure in aging vascular endothelial cells
平野勝也, 平野真弓
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 67-67, 2025.
Japanese Article P8. An oxidative stress study and the high-performance radical capture medicine which Japan preceded
上林將人1, 中西郁夫2, 森川敏生1, 松田久司1,3
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 68-68, 2025.
Japanese Article P9. Pharmacologic search of volatile organic compounds of heating-type cigarette mainstream smoke bringing about the ferroptosis of the vascular smooth muscle cell
新海良祐1, 真崎雄一2, 三輪聡一3, 堀之内孝広1
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 69-69, 2025.
Japanese Article P10. The AM-RAMP3 signal inhibits myocardium ferroptosis and protects heart from DOX cardiotoxicity
GUO QIANQIAN1, 桜井敬之1,2, 田中愛1,2, 神吉昭子1,2, 新藤優佳1, 林真倫那1, Zhang Yan1, Li Peixuan1, 星山健1, Li Jiake1, Duan Jun1, 赤平あすか1, 新藤隆行1,2
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 70-70, 2025.
Japanese Article P11. A case of the heart failure due to the light chain storage disease that suffered from differentiation with AL amyloidosis, and needed discussion with blood tumor department of internal medicine about a treatment strategy
吉田直人1, 中村研介2, 矢田貝菜津子2, 平井雅之2, 松原剛一2, 衣笠良治2, 加藤克2
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 35: 71-71, 2025.
▲